ÚOÚÄÔÒžÎþ­í÷Ͷ¡ãI÷L÷pÆÇ­®ÅóÎ�

Three Dimensional Medical Imaging

- Clinical Usefulness and Current Limitations -


ðÜãcùaþAª@Kazuhiro Katada, M.D.

ãÁãcðóÔâÅqƦΌÉwÅqƦÉwðä

Fujita Health University, School of Health Sciences


­PªD­ê­¦­§­ƒ I ­QªDË÷pÚOÚÄÔÒžÎþ­íÔȶ— I ­RªDË÷pÚOÚÄÔÒžÎþ­íö‰Î�ã_

1) ËÚt­íÚOÚÄÔÒžÎþ­ƒÎë­á­Žð]ÅÀ I 2)Ô«°fª[°^­íÚÀ I 3)ÿíþâɶo

4)ã”ðäÎgÆDðìÔ`°V°~°·°Ôª[°V°½°ã I 5)¶Ã÷ÿÚõÉï I 6)÷Ͷ¡ð]ÅÀ

­SªD­¬­’­�­ƒ


°A°u°X°g°Å°N°gªFª@ѧäN­íË÷pÚOÚÄÔÒžÎþ­íÆiðˆ­êƸ­ƒÑ}­�­Ê­ŽªD­µ­©­µÃ�ðž­�ªC­È­í÷Ͷ¡ãI÷L÷pÆÇ­»Ém÷¤­Ò­�­¸ð»ö“­êö¢­²¶Ð­é­ÐªC㜶’÷Ͷ¡­…­íÅõ÷p­ˆÃ�ðäÚ{Æ ­ƒÔË­�­�­€­¢­ŽªD­±­�­êªCË÷pÚOÚÄÔÒžÎþ­íÑZ¶pªCãKÅõ­é­‚­ƒö¢­²ö¢ÅÝÔííö‰Î�­»Î¦Ù ­á­Ž­±­®­ƒ­¾­ŽªD­±­±­�­êªCÚOÚÄÔÒÆfâf­íÔȶ—­ƒ­¬­ø­Ž÷L÷pÆÇ­ƒ­å­¢­€ÆU­�ðï­Ž­®­®­ˆ­ƒªCÔ«°fª[°^ªC°A°v°É°Pª[°V°½°ãªC°nª[°h°E°G°A­é­‚ÔÈÚõã_­�­íÚOÚÄÔÒÆfâf­íö‰Î�ã_­ƒ­å­¢­€ÙlÚ@­ÝÚÚ­ ­ŽªD

°Lª[°¶ª[°hªFÚOÚÄÔÒžÎþÆfâfªC°w°É°J°Ñ°X°L°°°ãCTªC°{°É°·ª[°¥°fª[°^ªC°{°É°·ª[°¥°Ô°ã°_°É°ã°O

Abstract: Despite recent rapid progress of medical imaging, three-dimensional (3D) imaging has not yet to be a diagnostic modality of choice in most of the clinical fields. This is because that current 3D imaging still possesses number of limitations and hazards in both technical and clinical aspects. In this paper, current clinical applications of 3D imaging were reviewed, and the limitations of 3D imaging technique in various medical fields were discussed.

Key words: Three-dimensional imaging, Helical scanning CT, Volumetric data, Volume rendering


­PªD­ê­¦­§­ƒ

ѧäNªCCTªCMRI­é­‚ƦÎí¶”ð–­ÝÚOÚÄÔÒãI­ƒÔvλ­á­ŽÑZ¶p­íäÐâB­®ªCÚOÚÄÔÒžÎþ¶Ã÷ÿÑZ¶p­íÃ�äæÅÈ­ƒ­¾­�ªCƦÎí­íÚOÚÄÔÒžÎþ­Ýã²­Ž­±­®­êä˜ö™ãI­ƒ÷eÃÍ­®­é­ç­¸ªD­µ­©­µÃ�ðž­�ªC­È­í÷Ͷ¡ãI÷L÷pÆÇ­»Ém÷¤­Ò­�­€­¢­Ž­í­êö¢­²Ã�ðä­íð»ö“­ƒ÷ø­†­ç­€­¢­ŽªD­†­¸ªCÚOÚÄÔÒžÎþ­ƒÎë­á­ŽÃ‹Út­íÑЭ¢ÉœÎñÉ«­®­ê÷ÊðÊ­ƒªCÚËÙó­í㜶’÷Ͷ¡­…­íÅõ÷p­êÃ�ðä­íÚ{Æ ­ƒÔË­�­�­€­¢­ŽªD­±­í÷ÿ÷R­êªCË÷pÚOÚÄÔÒžÎþ­íÑZ¶pªCãKÅõ­é­‚­ƒö¢­²Î¸­Ð­íö¢ÅÝÔííö‰Î�­»Úc­Ò­�­€­¢­Ž­¸­§­�­Ê­ŽªD­±­±­�­êªCÚOÚÄÔÒË÷pžÎþÆfâf­íÔȶ—­ÝÆU­�ðï­Ž­®­®­ˆ­ƒªC÷Ͷ¡Ã‹­í÷¤¶�­©­�ÔÈÚõã_­ƒ­¬­ø­Žö‰Î�ã_­ƒ­å­¢­€ÙlÚ@­ÝÚÚ­ ­ŽªD

­QªDË÷pÚOÚÄÔÒžÎþ­íÔȶ—

ÚOÚÄÔÒžÎþÆfâf­í÷L÷pÆÇ­»Ù�­ˆÎªÉœ­©­�äF­§­�­�­¸ð»ö“­®­µ­€ªCÉeÚ’Ùþðaðì­ƒÎë­á­ŽÚ�¶pÚxŽ­»Ñã­¡­�­�­ŽªD­®­Ð­ƒÔ`ÆÂÉOÅé÷íþ­ÝâºÆS­®­µ­¸Ú�¶pÚxŽ­…­íÅõ÷p­êªC­ô­òÚË÷p°Ô°x°Ñ­ƒâB­µ­€­¢­Ž­®Ùl­Ï­�­�­ŽªD

Fig.1ª@É�öæðÁÚGÙþƆ

­Ò­�­ƒÑ§äN­�­êªClaser lithography­é­‚­ƒ­¾­ŽÚËð¬ÎŒ°­°f°Ñ­»ã±ãŸ­Ò­�ªC¶pÎOÔÄ㢭ƒ÷p­¢­�­�­Ž­†­�­ƒäÐãW­µ­¸ªDÃ�ðžªC­±­±ÆääN­�Ñ}έƒðªÑy­µ­å­å­Ê­Ž­í­»ÔÔÉ‚Ôn­íÚOÚÄÔÒÆfâf­�­Ê­ŽªDÔÔÉ‚Ôn­êªC΢ÅeÙ†ãÉ÷^­ƒ­¾­�Ù­­¢°R°ã°g°Å°X°g­Ýã²­Ž­±­®­»­�­Ç­Ž­¸­§ªCÙþÙ\΢­®ãø÷l­ƒÚOÚÄÔÒÆfâf­ƒãK­µ­€­¢­ŽªD­®­Ð­ƒ÷L÷pÆÇ­»äF­§­�­�­€­¢­Ž­í­»ªCã»ðä÷íþ­ƒ­¬­ø­Žä]ã¨ö‡ڭíÆfâf­�­Ê­ŽªDã¨ö­íÚOÚÄÔÒãI­éªhöc­�­ ªh­�­Ê­Žä]ã¨ö‡ڭíð`¶o­êªC÷ÿù_ãI­ƒ­ˆÚOÚÄÔÒžÎþÆfâf­ƒãK­µ­€­¢­ŽªD

Fig.2ª@ÎOÔÝâæã¨öÂã¨ö‡Ú

­±­�­�­íð»ö“­ƒ­¬­¢­€ªC÷Ͷ¡ãKÅõ­»Ém÷¤­µ­¸ªi­Ê­Ž­¢­ê­µ­å­å­Ê­Žªj÷ÿ÷R­®­µ­€­êªCÃéż­í¶äã_­»Ùl­Ï­�­�­ŽªDξÃ�­ƒªCÎë¶ó­®­é­ŽÙ\΢­í°R°ã°g°Å°X°g­»Ù­­ÐªCÉ…ÆS÷íþ­íâɶo­»÷eÃÍ­�­Ê­ç­¸­±­®ªCξ㖭ƒªCÆfâfªEÚÁ÷̶‹Îë¶óÙ\΢­í÷¤ÎíãI­éäcí»¶d÷v­é­±­®ªCξÚO­ƒÚË÷pÅȶ‹­íÙ�ÎŒ­íö‰Î�ã_­�­Ê­ç­¸°fª[°^Ú¾ã²ÚõÉï­»ªC°w°É°J°Ñ°X°L°°°ãCT­íã±ãŸ­ƒ­¾­�°N°É°A­Ò­�­¸­±­®­»Ñã­¡­�­�­ŽªD­á­é­’­ÀªC°N°É°j°J°Ñ°jª[°Y­»­Ê­�ªC°fª[°^ھ㲪EÚOÚÄÔÒÎþÙ\ÆÂ­»÷eÃÍ­�ªCÉÒÚñ­íðÅâS­»¶Ð­é­¢­±­®­»ªCÚOÚÄÔÒÆfâfª^Ú�¶pÚxŽ­íÚË÷pÅÈ­ƒ­¬­¢­€¶d÷v­®Ùl­Ï­�­�­ŽªD

­RªDË÷pÚOÚÄÔÒžÎþ­íö‰Î�ã_

1) ËÚt­íÚOÚÄÔÒžÎþ­ƒÎë­á­Žð]ÅÀ

ÑZ¶pãIö‰Î�ã_­íÎO­ƒªCÔȶ—­ƒ­¬­ø­ŽÃ‹Út­íÚOÚÄÔÒžÎþ­ƒÎë­á­ŽÚpƬ­ƒ­å­¢­€­†­üÙl­Ï­€­ ­¸­¢ªDѧäN­©­é­�÷ÿÅÝ­»Æi­ ­å­å­Ê­Ž­®­ê­¢­ÏªCËÚtªC­®­Ð­ƒðœÚèÆŸÅéË­íÚOÚÄÔÒžÎþ­ƒÎë­á­ŽÚ¾­�Îg­ ­êªCÃ�ðä­Ý¶þ­ÇäŠÉrãI÷‰âW­®Ô²­’­«­Ž­Ýã²­é­¢ªD­È­íù_Ñâ­®­µ­€Ñã­¡­�­�­Ž­í­»ªCªhÚÓÃæâf­í­ ­�ÎS­€­íÆfâf¶”ð–­Ýã²­Ž­±­®­»Ååä\­�­Ê­�ªCÚOÚÄÔÒžÎþ­�­å­øÅç­Ï­�­�­Ž¶”ð–­ê­é­¢ªhªCªh­¾­ÐÔP÷ž­Ò­�­¸Å¾ÎþÆfâfË­êÚÓÃæâf­©­�ã»­í­é­©­�ÚOÚÄÔÒÙ\΢­ÝÙ\âz­�­Ç­Žªh­®­¢­Û­ˆ­í­�­Ê­ŽªDÃ�ðž­�ÉOÅéË­êªCÉT­µ­€ðœÚèÆŸÅéË­¾­�­ˆÙDÃîãI­�­Ê­ŽªD­±­í÷ÿ÷R­êªCðœÚèÆŸÅéË­»ã–ÚÄÔÒ­í°t°B°Ñ°¥­Ý㜶’Ñ®ö±­íâ¹Æò­íÎë¶ó­®­µ­€­¢­Ž­í­ƒÎë­µªCÉOÅéË­»¶’­ƒÉÒÚñ­ÝÚOÚÄÔÒ­íÚËÎí­®­µ­€Î¬­Ï­€­¢­Ž­±­®­ƒ­¾­ŽªDðœÚèÆŸÅéË­ƒ­®­ç­€Ã‹÷pžÎþ­Ýã²­ŽöòãI­êªhÆfâfªh­ƒ­Ê­Ž­»ªCÉOÅéË­ƒ­®­ç­€­êªhÚOÚÄÔÒãI­é°I°É°G°ã°eª[°V°½°ã­Ýã²­Ž­±­®ªh­»­È­�­®ãø­¦­Ð­�­¢­ƒ¶d÷v­é­í­�­Ê­ŽªD­±­íã_ÚOÚÄÔÒžÎþ­êªC­¸­®­Ï­È­�­»­®­Ð­ƒÆV­µ­¢Æfâf¶”ð–­ÝɆ­†­é­¢¶�Ù½­�­ˆªC­È­�Ú©Îí­�­Ê­ŽâšãxÉOÅéË­í°jª[°Y­ƒÙ½âv­µ­€­¢­Ž­®­¢­Ï­¾­ÛªD­¢­ü­�­ƒ­Õ­¾ªCËÚt­íÆ�öŒ­®­È­í°o°b°N°O°Å°E°ã°h­ƒ­¾­ç­€ÚOÚÄÔÒžÎþ­È­í­ˆ­í­ƒÎë­á­ŽÚ¾­�Îg­ ­»Ãô­é­Ž­±­®­êöçÑL­Ò­�­Ž­×­Ç­�­Ê­ŽªD

2)Ô«°fª[°^­íÚÀ

ÚOÚÄÔÒžÎþÆfâf­ƒ­¬­ø­ŽÑZ¶pãI­éö‰Î�ã_­íξÃ�­êªCÚOÚÄÔÒÎþ­í­ˆ­®­®­é­Ž°fª[°^­íÚÀ­�­Ê­ŽªD

Fig.­Rª@Ô«°fª[°^­íÙá­ƒ­¾­ŽÚOÚÄÔÒžÎþ­ížÚÀÅŸÎP

Ã�äæ­ƒÔÈÙ ­í°fª[°^­íðiÚÀ­êªCÅÝÎþãxªCS/NªC°Aª[°`°t°@°N°g­é­‚­»÷vѪƷ¶¥­ƒãõâB­µ­€­¢­é­¢¶�Ù½­»Î¸­¢ªD­®­Ð­ƒÎíÚÓðžÔŸ­í°T°ã°v°É°ã°O°Ôª[°g­»ÚÓÃæâfö歃䊭µÎŒ­Ç­Ð÷˜­ç­€­¢­Ž­±­®­êªC°fª[°^­íãúðžÆÇ­ÝÚü­’­Õ­Ž­®­®­ˆ­ƒªCpartial volume effect­ÝÎÿÎŒ­Ò­Õ­€¶”ð–÷æ­ÝÚü­’­Õ­ŽÎŒ­Ç­éԫÚ­®­é­ç­€­¢­ŽªDÅåä\­éÔË­�ÚËÔ¿°X°Å°C°Xðÿ­Ýäö­Ð­µªCÎíÚÓðžÔŸð»ÅÝä\­ÝÔŸ¶‹­Ò­Õ­Žãw÷ê­»ðK÷v­�­Ê­ŽªDÅŠªX­ê0.8mm°X°Å°C°X­ÝCTÎðâu­ƒÚËÎð­á­Ž­±­®­ƒ­¾­�ªCÎŒðÿ­éÎíÚÓðžÔŸð»ÅÝä\­íÔŸ¶‹­Ýã²­€­¢­ŽªD

Fig.­Sª@ÚËÔ¿°X°Å°C°Xðÿ­ƒ­¾­ŽÔÔÉ‚ð`¶oä\­íÙá

Fig.­Tª@0.8mm°X°Å°C°X­ƒ­¾­ŽÚOÚÄÔÒÎþªiÚÑÆ_ÔoÉ‚ªj

ÚOÚÄÔÒžÎþÙ€Ù\ÆÂ­ƒä¼­Û¶”ð–÷æ­íÔ½÷Ú­ˆÎŒ­Ç­éö‰Î�ã_­�­Ê­ŽªDÃ�äæ­ƒÚOÚÄÔÒÎþÙ\âz­íãr¶‹­�­êªC÷íþâɶo°G°Åª[ªC°­°f°É°ã°Oŧ⚭íð¸ÉÉÅÈÔ¿Åæ­ƒ­¾­�ªCԫžÎþ­íÚÿ­åäÖÙ×¶”ð–­íÃ�ðä­»Úü­’­�­€­¢­ŽªD­±­í­¸­§ªCÚOÚÄÔÒ÷p°fª[°^­êâæ¶’Æfâf÷p­íã–ÚÄÔÒžÎþ­¾­�­ˆ­©­é­�°Iª[°oª[°T°ã°v°É°ã°O­Ò­�­€­¢­ŽðK÷v­»­Ê­ŽªD

Ô«°fª[°^ÅÝÎþãx­®­µ­€­ê­‚­íâšãx­ÝöòðW­®­á­×­Ç­�­Ê­‘­Û­©ªHª@­¢­’­Š­Ž°ä°@ª[°`°°°Ñ°É°A°É°e°B­íÔ©ân­©­�Ô²­Ï­ëªCÆlÉï­íÉ«ÉoƦ÷ÿÉw¶‹ªCžÎf­‰°t°Ôª[°¥°Ôª[°g­ÝÃîÚø­Ò­Õ­é­¢Ù�â‡É”¶¥°Ô°x°Ñ­»öòðW­®­Ò­�­Ž­×­Ç­�­Ê­ŽªD­á­é­’­ÀªC°}°g°É°b°N°XÆä2000x2000ªCÎíÚÓðžÔŸ­ƒãúðžÆÇ­í°fª[°^ð»ðz­ÝÚÿ­ÀªCÔvλ12ª[16°r°b°gªCð\ÚÏ8°r°b°gªCã¨Å¾Îþ­í¶�Ù½­êðbÉï30°t°Ôª[°¥­»ö]­†­µ­¢ªDöÒù_ªCÔȶ—­íÙHÉwãIä\÷ê­�­ê­±­�­�­í°X°y°b°N­êö]­Þ­×­Ð­ˆ­é­¢­»ªC¶Ð­é­Ð­®­ˆÔȶ—­í°fª[°^­íÚÀ­»ÃÒã|ãI­ƒðs¶\ð»­�­Ê­Ž­±­®­êªCäFÚø­µ­€­¬­ÐðK÷v­»­Ê­ŽªD­±­íÙ¥­íÙ�¶Å­ƒâ¾ÚÏ­µ­¸ðœÚèÆŸÅéË­íÑ^ö‰­íÃ�Ú­êªCÚOÚÄÔÒžÎþ­íÚÿ­åÆfâf¶”ð–÷æ­»ªCÚÓÃæâfªiԫžÎþªj­¾­�­ˆ¶Ð­é­¢­±­®­ƒ­¾­Ž­®Úv­’­�­ŽªD­ˆ­µ­ˆ­±­±­ƒÑã­¡­¸­¾­Û­é‰fö¤­é°fª[°^­Ý­ˆ­®­ƒªCÔ«°fª[°^­íÚÿ­å¶”ð–­Ý­á­×­€ð\ÔÈÅåä\­éÚOÚÄÔÒžÎþ­»Ù\âz­Ò­�­Ž­é­�­ëªCÆ^­íÚOÚÄÔÒžÎþÆfâf­»Ååä\­ƒ­é­Ž­®Úv­’­�­ŽªD­±­�­êÚ�¶pÚxŽ­ƒ­å­¢­€­ˆãø÷l­�ªCÙ×­¢ÔÔÉ‚ªEÆ_Ôo­Ý­ˆÉ†­ÞÙ×ö¤­éÅÝöUÙ\΢­íÙ€ÔÈ­»ö]­†­�­€­¢­Ž­±­®­êÔ²­Û­†­�­ˆ­é­¢ªD

Ô«°fª[°^­ƒÉ…­µ­€­êªCÚBÅeªiÚBÎþªjðžö@­íÙHðv­ƒ­¾­�ªCÉeÚ’°Aª[°`°t°@°N°g­ÝÙ�ÎŒÔË÷}­Ï­Ž­±­®­ˆ¶d÷v­�­Ê­ŽªD­†­¸ªCÔ«°fª[°^­ƒÉ†­†­�­Ž¶”ð–­íÚ’÷Þ­ˆ¶d÷v­�ªCÔȶ—­�­êªCÙþªCÔÔÉ‚ªCÆ_Ôo­é­‚ÆfâfªEÚ�¶p­ƒÙó­µ­€ðK÷v­®­Ò­�­ŽÙ\΢ÎS­€­ÝâPÃ�­í°­°_°É°e°B­�ð`¶o­�­Ç­é­¢ã_­ƒö‰Î�­»­Ê­ŽªD­±­íã_­ƒÉ…­µ­€­êªCѧäNªuÃôÚ’°­°_°É°e°BÉï­ížÎþ¶d­èÙ½­’­Õªv­»ÚÚ­ ­�­�­€­¢­Ž­»ªCÙËðWÔn­ÝÃ�âv­Ò­Õ­ŽÅ§âš­�­íÔ‘Ùá­®ªCðÁÆäÔÄÙüªE°t°Ôª[°¥Îðâ·­é­‚­ƒä¼­ÛÉÒÚñðÅÅ×­íÎÿÎŒ­»ö‰Î�ã_­®­µ­€Úc­Ò­�­€­¢­ŽªD­®­Ð­ƒMRI­íÚ´¶�ðsÑìÃ�ÆÇ­ƒÑNÚ­á­ŽÑ—ÉïãI­éùc­ ­êªCä’ÔÄÎí­Ó­®­ƒ­pâl­»Ãô­é­Ž­¸­§ªCɨÎS­éð‰ÆÒ­ê٢㕭�­Ê­ŽªDÃ�ðž­�ªCâPÃ�°­°_°É°e°B­�­�­Ç­Ž­²­øÎ¸­Ð­í¶”ð–­Ýã²­Ž­×­ÐªC°­°_°É°e°BÚ©Îí­íð`¶oä\ÅŸÎPãw÷ê­ÝÎî­Ž­×­Ç­�­ê­é­¢ªD

3)÷íþâɶo

ÚOÚÄÔÒžÎþÚË÷pÅÈ­ƒãö­¸­ç­€­©­é­�­üÚÿ­À¶o­Ò­�­Žä‡äÈ­ƒªCªhÎþÙ“ÆÂÚñ­ƒ­¾­ç­€Å¾Îþ­»Ãô­é­ŽªhªCªh­‚­�­»ÆÒ­µ­¢Îþ­é­í­©­’­©­�­üªCÆM÷p­�­Ç­é­¢ªh­®Ô²­Û­ˆ­í­»­Ê­ŽªD­±­�­êÉ…ÆS÷íþ­íâɶoŧ⚭»ªCÙ“ÆÂÚñ­Ê­Ž­¢­êÙ“ÆÈÉåÑǪE¶ÝÔ¶ªi­µ­Ç­¢âl­é­‚ªj­ƒ­¾­�Ù¦ÅE­Ò­�­Ž­±­®­ƒ­¾­ŽªD

Fig.­Uª@ÑÇÉEâlÆ â�­ƒ­¾­ŽÚOÚÄÔÒžÎþ­íðìÅÈ

Ú¢÷Ã÷íþâɶo­êÚOÚÄÔÒžÎþÙ“ÆÈ­ƒ­Ê­¸­ç­€­íÙ�ÎŒ­íö‰Î�ã_­�­Ê­�ªCθ­Ð­íÔÛѺÚñ­ƒ­¾­�Æäθ­Ð­íÚÚ­ ­»­é­Ò­�­€­Ç­¸ªD­µ­©­µÙ­°R°ã°g°Å°X°gÙ\΢­Ý¶þ­ø­ëªCö¢­²ÔÃâ�ãI­éÚ�ö@­êã²­�­�­€­¢­é­¢ªD­±­�­ê÷íþâɶo­íö{ÚÀ­»ÆÒ¶’Ù\΢ªCÃô¶’Ù\΢ªC­Ê­Ž­¢­ê­È­í÷¹Úñ­íÑÇÉEäÈâ�­ƒ­Ê­�ªC­Ê­ŽÃîöÁ­�žÎþÆfâf­íö{ÚÀ­®­ˆ­¢­Û­×­ÇäÈâf­ÝѪ­§­�­�­Ž­±­®­ƒ­¾­ŽªDâùÚñ­êÃéÎO­¾­�ªCªu÷íþâɶo­êªhã‚Åe°Ô°|ª[°g­Ý¶Î­Ð­±­®­®ãúÅÀ­íË÷ÌÙsÃתh­�­Ê­Žªv­®ÚŒâ£­µ­€­Ç­¸­»ªC­±­�­ê­á­é­’­ÀªCªh¶n÷ž­µ­¸Ã‹Út­®ãøãú­íÅÝöUÉwãIªEða÷ÿÉwãIâmÚø­ƒÉ”­Ì­¢­¸÷íþâɶo°A°Ñ°S°É°Y°¥­»ðK÷v­é­±­®ªh­ÝÃîöÁ­µ­€­¢­ŽªD­±­í­¾­Û­é°A°Ñ°S°É°Y°¥­»ã²­�­�­Ž­†­�­êªCÆ�öŒ­íËÚt­»Ã‹ÉwãIªEö@ãIÆîäC­ÝðÅ­ç­€÷íþâɶo­ÝÙs­ç­€Ùs­Ð­×­Ç­�­Ê­‘­ÛªD­¸­²­µªCÉm­©­ƒÔȶ—­ƒÅ÷­¢­€Ã‹Út­ƒÉ¨ÎS­ƒÎ…­’­Ž­¾­Û­é°A°Ñ°S°É°Y°¥­íÙ\âz­êðsÅåä\­©­ˆ­µ­�­é­¢­»ªCÉeð»ö“­ƒ­¬­¢­€Ã‹Út­íâɶo­Ý¶ð­ø­Ž­¾­�°C°ã°e°É°W°F°ã°g­é°A°Ñ°S°É°Y°¥­íÉJäЭê¶[ð»Ååä\­®Ùl­Ï­�­�­ŽªD

4)ã”ðäÎgÆDðìÔ`°V°~°·°Ôª[°V°½°ã

ÔÈÙ ­íÚOÚÄÔÒÚ�¶p°V°·°~°Ôª[°V°½°ã­ƒ­¬­ø­ŽÙ�ÎŒ­íö‰Î�ã_­êªCâeÆÇÎí­®­µ­€­íƦÎí­íÚ¾­�õ­¢­ƒ­Ê­ŽªDÔÈÚË­íÚ�¶pÚ�ÑZ­ƒ­¬­¢­€­êªC­¢­©­ƒðaðìðä­ƒãõâB­á­Ž­©­»­®­Ð­ƒÉí÷v­�­Ê­Ž­»ªC­±­í¶�Ù½ªCðaΰ­ÝÚ¾­�Ãê­–­�­¢­ŽÆÒ¶’ðäð»­Ý¶þÑÚªiƯْªj­á­Ž­®­¢­Û°A°v°Ùª[°`­»­®­�­�­Ž­±­®­êÑH­�­Ê­ŽªDθ­Ð­í¶�Ù½ªCÆÒ¶’ðäð»­…­íÆN¶P­êÙ�¶ÂÔË­ƒ÷ø­§ªCÆÒ¶’ðäð»­ÝÃÒär­Ê­Ž­¢­êðëÃæ­Ò­Õ­Ž­±­®­ƒ­¾­�ðaΰðä­ƒãõâB­á­ŽªD­±­í­¸­§Æ^­ƒÚ�¶p°A°v°Ùª[°`­Ý°V°~°·°Ôª[°g­µ­¾­Û­®­á­�­ëªCƦÎí­íðìÔ`¶Ã÷ÿ­êäÝ­ø­€­êâæ­�­é­¢ªD­±­íã_­�ªCѧäNâeÆÇðìÔ`¶Ã÷ÿ­…­íÉ…ÆS­»Ù­­†­�­å­å­Ê­Ž­±­®­êªCÎŒðìö]­†­µ­¢ðìÅÈ­�­Ê­ŽªD¶Ã÷ÿÙHÆä­íÎŒðÿ­éÎÿÅç­Ýä¼­Ûð¬ÎíðìÔ`¶Ã÷ÿÚ�ö@­íÉm÷¤­êªCÚOÚÄÔÒÚ�¶p°V°~°·°Ôª[°V°½°ã­ƒ­¬­¢­€Ôȶ—­�Ù�­ˆÉœÎñ­Ò­�­€­¢­Ž­±­®­�­Ê­ŽªD

5)¶Ã÷ÿÚõÉï

öcÎŒ­é¶Ã÷ÿÚõÉï­êªCÚOÚÄÔÒžÎþÆfâf­ƒ­¬­ø­ŽÔÈÙ Ù�ÎŒ­íö‰Î�ã_­íÃ�­å­�­Ê­ŽªD­®­Ð­ƒ°fª[°^­í‰fö¤ãx­»Îÿ­µªC°{°É°·ª[°¥°Ô°ã°_°É°ã°O­Ý΋ð\­®­á­ŽÙ­ÚÄ­í°A°Ñ°S°É°Y°¥­»Î¸÷p­Ò­�­Ž­ƒ­å­�ªC¶Ã÷ÿÚõÉï­êÎÿÎŒ­µ­å­å­Ê­ŽªD­†­¸ªCÚ�¶p°V°~°·°Ôª[°V°½°ã­ƒ­¬­¢­€­êªC­È­íö{ÚÀ­»ÚÑã_­íðìÙXªCƯْªCðìÔ`­é­‚­ížÎþÅçÙH­Ý÷p­¢­¸°g°Å°CªE°A°ã°hªE°G°Åª[ªitrial and errorªj­�­Ê­Ž­±­®­ÝÙl­Ï­Ž­®ªCžÎþÙ“ÆÈª^ð\ÚÏ­í°É°A°Ñ°^°C°¥ÆÇ­êªCƉÎë¶Ö­�­é­¢ðKÆ{­í¶ÝÔ¶­®Ô²­ç­€­¾­¢ªD

­È­í­ô­©ªCÎŒ÷æ­í°fª[°^­Ý٭έ�°¶ª[°N°X°eª[°V°½°ã­ƒã]Î÷­á­Ž°l°b°g°¶ª[°NÑZ¶p­ˆªC¶d÷v­éÙ¥öò­íÃ�­å­�­Ê­ŽªD

6)÷Ͷ¡ð]ÅÀ

ѧäN­íÑ}έéäÐãW­ƒ­ˆ­©­©­’­�­üªCÚOÚÄÔÒžÎþÆfâf­»Ã‹÷ÌÚÜÅ•Ã�äæ­©­�ÙL­ÐÚ—­øãŸ­�­�­�­¸­©­®Ô²­Ï­ëªCö¢­²ðs¶\ð»­®Ô²­’­«­Ž­Ýã²­é­¢ªD­±­í÷ÿ÷R­êªC°R°ã°s°·ª[°^ÚxŽ­ƒ­¾­Ž°A°h°o°ã°eª[°W­ÝªCÉÒÚñ÷\Ô‹­íÔŸ¶‹­®­µ­€ö²Ém­ƒ¶¯ö²­�­Ç­€­¢­é­¢­±­®­ƒ­¾­ŽªDÙÁÔ‹­êªCprospectiveªCrandomizedªCdouble-blinded study­ƒ­¾­�ªC­È­íÔ¿Åæ­ÝÑqÉìãIªEÉwö‰ãI­ƒ¶¯ö²­á­Žãw÷ê­»ðK÷v­®­é­‘­ÛªD­È­í­¸­§­ƒ­êªCöZ­µ­¢÷Ͷ¡­í¶�­�θÆä÷‡­ƒ°X°g°Ô°XöÒ­ÐÚg÷p­�­Ç­Ž­†­�­ƒ¶Ã÷ÿÚõÉï­ÝâZ¶k­á­Ž­±­®­»ªC­é­ƒ­¾­�­ˆö]­†­�­ŽªD

­SªD­¬­’­�­ƒ

Ãé¶‹ªCÚOÚÄÔÒË÷pžÎþÆfâf­íÔȶ—­®ö‰Î�ã_­ƒ­å­¢­€ù_­¦­€­Ç­¸ªD

¶]÷êCÚOÚÄÔÒžÎþÆfâf­ƒÆìуãI­ƒÔg­’­ŽÃ‹Út­êªCÙHÉw­íÔȶ—­Ý÷¦­Ž÷]­�ªCÙHÉwÎÛ­ƒÎë­µÔÈÚË÷£­�­µ­¸÷vѪ­ÝÙT­Ï­€­Ç­¸ªDö{Ùe­�¶q­×­�­�­¸ÃîÔ©­í­é­©­ƒ­êªCÔȶ—­�­êÚËÔÈ٢㕭é÷vѪ­ˆÎ¸­ÐªCÙHÉwãI­éÔ©ân­©­�­á­�­ëªhö\ù_ªh­®Î¬­Ï­�­�­Ž­©­ˆ­µ­�­é­¢ªD

Ã�ðž­�Ë÷ÌÎÛ­©­�­ ­�­ëªCË÷Ì­ƒ÷p­¢­�­�­Ž°cª[°Ñ­íðiÚÀ­êªC­È­�­»ÉÒÚñ­íÔâÙNªEƦö¸­®â¹ÆòÉ…­’­Ž­»Ôí­ƒªCö˜­�­Ê­�Ú�¶pÉ’Ñ•­�­Ê­�Úsäíði­¾­�­ˆÙ­­¢ðiÚÀ­»÷vѪ­Ò­�­Ž­í­êãöÎR­�­Ê­ç­¸ªD­®­±­‘­»ÚOÚÄÔÒÎþ­íË÷ÌÅõ÷p­ƒÉ…­µ­€­êªC°f°U°C°ãªEÔûâzð»ö“­êÔ²­Û­ƒ­¬­¾­ë­üªCÅfžªCTV°R°}ª[°V°°°ÑªCÅæ­€­êÅ®â‘÷pTV°Qª[°¥­ƒ­†­�âx­�­Ý­®­ç­€­¢­Žðäð»­»­Ê­ŽªDË÷pÚOÚÄÔÒžÎþ­êªC­È­íö{ÚÀ­©­�Ô²­ç­€ªC­±­�­�­íð»ö“­Ý­ê­Ž­©­ƒ÷¸Å’­á­ŽðiÚÀ­»ã²­�­�­€ãöÎR­é­í­�­Ê­ŽªD°w°É°J°Ñ°X°L°°°ã­ƒ­¾­�ö{ÉiãI­éÚË÷pÅÈ­»Ún­†­ç­¸ÔÈÙ ­êªCãoÚR­ƒ­¸­®­Ï­�­ë÷ÊÚR­�­í°g°Ôª[°j°ã°O­Ý¶I­ÏªC­¾­�Ù­­¢ð™­ÝöòÚw­µ­€ão­�Ún­§­¸­®­Ç­ƒ­Ê­¸­ŽªDão­Žð™­»Ù­­ø­�­ëªC­È­�­²­øÔ‘ÆfªEË÷Ìŧԑ­é­‚­íÉ‘ÔøÆÇ­ˆÙ­­†­Ž­í­êãöÎR­�­Ê­ŽªDÙ­­¢ð™­íâü¶‹­ÝÃËÎS­ƒÑƒ­§­Ž­¸­§­ƒªCÅŠªX­êÉü­Ï­€ªhɾÔ�ö�ªh­®­é­ç­€ªCö{÷ÃöòÚw­á­×­ÇöòðW­Ýã`­Ï­ŽÆîö±­»­Ê­Ž­®Ùl­Ï­ŽªD


ª°ð¦Ô£ª³

1. ðÜãcùaþAªF°w°É°J°Ñ°X°L°°°ãCT­ÝâºÆS­®­µ­¸­RÚÄÔÒžÎþÆfâf­íÔȶ—­®ö‰Î�ã_ªD Medical Imaging Technology, 13(3):208-214, 1995.

2. ÷Žö¯¶GâqªCâÕùe¶°Ã�ùYªFã»ðäMRIžÎþ­íâmÚø­ƒÉ”­Ì­Ðک㨰Z°O°ª°ã°eª[°V°½°ã­®3ÚÄÔÒð\ÚϪDË÷pãdÚq­®Æ¦ÎíÙHÉwªD25(1)1-7, 1987.

ð¦­íƾ㻭…